Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00397748 · ClinicalTrials.gov registry record
PET Scanning of Adults With Attention Deficit Hyperactivity Disorder (ADHD)
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 16
- Enrollment target
NCT00397748 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 16 participants.
The verdict
NCT00397748 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
This study will explore the brain in men with and without attention deficit hyperactivity disorder (ADHD). It will use positron emission tomography (PET) and magnetic resonance imaging (MRI) to study brain function and nerve cell communication involving phospholipids (fatty molecules that make up the covering of nerve cell fibers in the brain and are involved in communication between the cells). It will also look at how nerve cell communication is related to blood flow. In particular, the study will explore communication through the dopamine system, which is one of the main neurotransmitter systems in the brain involved in ADHD. Healthy men and men with ADHD between 18 and 55 years of age may be eligible for this study. Participants undergo the following procedures: "\<TAB\>Medical history and psychiatric and medical evaluation, including blood and urine tests. "\<TAB\>MRI scan. This test uses a strong magnetic field and radio waves to obtain images of the brain. The subject lies still on a table that slides into the scanner (a metal cylinder) during the scanning. "\<TAB\>PET scanning. The subject lies on the scanner bed with his head held still using a special facemask. A catheter (plastic tube or needle) is placed in an artery to collect blood samples and in a vein to inject radioactive isotopes for measuring blood flow and phospholipid metabolism. Scans are done after an injection of a saline solution and again after injection of apomorphine, a medication that turns on dopamine receptors in the brain. The injections are given under the skin of the abdomen, about one and a half hours apart....
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2006-09-15 |
| Est. Completion | 2012-11-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00397748
The ClinicalTrials.gov registry entry for NCT00397748 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00397748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00397748 about?
NCT00397748 is a clinical study titled "PET Scanning of Adults With Attention Deficit Hyperactivity Disorder (ADHD)". This study will explore the brain in men with and without attention deficit hyperactivity disorder (ADHD). It will use positron emission tomography (PET) and magnetic resonance imaging (MRI) to study brain function and nerve cell communication involving phospholipids (fatty molecules that make up th...
What is the current status of trial NCT00397748?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2006-09-15. Estimated completion is 2012-11-27.
Who is sponsoring clinical trial NCT00397748?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.